| 價(jià)格 | ¥2480 | ¥10600 | ¥13800 |
| 包裝 | 2mg | 25mg | 50mg |
| 最小起訂量 | 2mg |
| 發(fā)貨地 | 上海 |
| 更新日期 | 2026-06-29 |
| 中文名稱:化合物 Deramciclane | 英文名稱:Deramciclane |
| CAS:120444-71-5 | 品牌: TargetMol |
| 產(chǎn)地: 美國(guó) | 保存條件: Keep away from direct sunlight,Keep away from moisture, Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 產(chǎn)品類別: 抑制劑 | |
| 貨號(hào): T001|T10996 |
| 名稱 | Deramciclane |
| 描述 | Deramciclane has high affinity for 5-HT2A and 5-HT2C receptors. It acts as an antagonist in both receptor subtypes and has inverse agonist properties for 5-HT2C receptors, but no direct stimulant agonists. |
| 體外活性 | Deramciclane is a new anti-anxiety drug that can bind to 5-HT2A/2C receptor with high affinity. The interaction between deracixan and serotonin 5-HT2C receptor was further characterized using receptor phosphoinositide hydrolysis assay and receptor autoradiography. Deramciclane antagonizes 5-HT2C receptor-mediated 5-HT stimulated phosphoinositide hydrolysis with IC50 value of 168 nM. In the physiological system of the choroid plexus nervous system, diracic clane can also reduce the hydrolysis of basic inositol phosphate by as much as 33% (EC50 = 93 nM), which indicates that deracic clane has inverse agonism at this receptor Agent properties. |
| 體內(nèi)活性 | Compared with basal levels, at any time point, doramamine 3 and 10 mg/kg did not significantly change dopamine levels, while at 40-100 minutes and 160-240 minutes, delamethasone 30 mg/kg was significant Increased dopamine levels (P <0.05). Deramciclane is a putative anti-serotoninergic compound that reduces 5-HT-induced phosphoinositide hydrolysis and multiple effects caused by serotoninergic agonists. The receptor binding curve of Deramciclane is comparable to that of ritanserin. Deramciclane has high affinity for 5-HT2A and 5-HT2C receptors. It acts as an antagonist in both receptor subtypes and has inverse agonist properties for 5-HT2C receptors without direct stimulatory agonist effects. In some animal experiments, deraciciran has been shown to have anxiolytic effects. |
| 存儲(chǔ)條件 | Keep away from direct sunlight,Keep away from moisture, Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 關(guān)鍵字 | EGIS3886 | EGIS 3886 | Deramciclane | 5HTReceptor | 5-HT2A Receptor | 5HT Receptor |
| 相關(guān)產(chǎn)品 | Cefaclor monohydrate | Cinchonidine | Dopamine hydrochloride | Sevoflurane | Cloperastine hydrochloride | Alverine citrate | Dapoxetine hydrochloride | Mianserin hydrochloride | Trazodone hydrochloride | Clozapine N-Oxide | Doxepin hydrochloride | 1,8-Cineole |
| 成立日期 | 2013-04-18 (14年) | 注冊(cè)資本 | 566.265100萬(wàn)人民幣 |
| 員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
| 主營(yíng)行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
| 產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
|---|---|---|---|---|
| 詢價(jià) |
河北冀肽生物科技有限公司
|
2026-07-27 | ||
| 詢價(jià) |
VIP1年
|
海南瀚海致遠(yuǎn)生物科技有限公司
|
2026-06-10 | |
| 詢價(jià) |
VIP1年
|
河南伊諾凱新材料有限公司
|
2026-06-11 |